Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial

The Lancet HIV 2026 Open access

Read full text
Authors: Felix Mhlanga, Daniel Szydlo, Ashley Mayo, Katherine Bunge, Lee Fairlie, Clemensia Nakabiito, Petina Musara, Nyaradzo M Mgodi, Sufia Dadabhai, Rachel Scheckter, Peter L. Anderson, Mark A Marzinke
+48 more Catherine A. Chappell, Luis A Gadama, Barbra A Richardson, Jeanna Piper, Sharon L Hillier, Bonus Makanani, Luis A Gadama, Linly Seyama, Taha E Taha, Mary Glenn Fowler, Carlotta Mabuza, Hermien Gous, Petina Musara, Z. Mike Chirenje, Naana Cleland, Roberta Black, Nahida Chakhtoura, Dianne M. Rausch, Teri Senn, James F Rooney, Zeda Rosenberg, Craig Hendrix, Lisa Noguchi, Abraham Johnson, Cheryl Blanchette, Jontraye Davis, Tara McClure, Lisa Levy, Richard H. Beigi, Sharon A Riddler, Devika Singh, Edward Livant, Lisa Rossi, Luis Duran, Mei Song, Ariana Katz, Alinda Young, Elizabeth Montgomery, Imogen Hawley, Marie Stoner, Ariane van der Straten, Iván C. Balán, Barbra A Richardson, Jennifer Balkus, Lena Kemel, Maricel Manalo, Tanya Harrell, Amanda Brown
DOI: 10.1016/s2352-3018(25)00307-8
Cited by: 2
References: 26

Fields of Study & Subjects

HIV/AIDS Research and Interventions Reproductive tract infections research HIV/AIDS drug development and treatment

Publication details

Journal / source
The Lancet HIV
Publisher
Elsevier BV
Volume
13
Issue
3
Pages
e176–e184
Publication date
10 February 2026
Language
EN